Jerome Cluzeau

Title: Jerome Cluzeau: Innovator in Pharmaceutical Chemistry

Introduction

Jerome Cluzeau is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes and compounds. With a total of 3 patents, Cluzeau has established himself as a key figure in the development of new therapeutic agents.

Latest Patents

Cluzeau's latest patents include groundbreaking work on processes for the preparation of beta-aminosulfone compounds. This invention relates to methods for synthesizing β-aminosulfone compounds, which serve as useful intermediates in the preparation of sulfone group-containing isoindoline-based compounds, specifically apremilast. Another significant patent involves catalyzed carbonylation in the synthesis of angiotensin II antagonists. This invention details an efficient synthesis of halogenated biaryl starting materials via Grignard chemistry, along with the reaction of catalyzed carbonylation of specific compounds using gaseous carbon monoxide or formic acid salts in an anhydrous solvent.

Career Highlights

Throughout his career, Jerome Cluzeau has worked with prominent companies, including Lek Pharmaceuticals d.d. His expertise in pharmaceutical chemistry has allowed him to contribute to various innovative projects and advancements in drug development.

Collaborations

Cluzeau has collaborated with notable professionals in his field, including Zdenko Casar and Gaj Stavber. These collaborations have further enhanced his research and development efforts, leading to significant advancements in pharmaceutical innovations.

Conclusion

Jerome Cluzeau's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of new therapeutic agents, showcasing the importance of innovation in the field.